We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $20.37, demonstrating a -6.43% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.53% for the day. Elsewhere, the Dow lost 0.71%, while the tech-heavy Nasdaq lost 0.93%.
Shares of the company have appreciated by 22.58% over the course of the past month, outperforming the Finance sector's loss of 2.07%, and the S&P 500's gain of 1.13%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 6, 2025. The company is expected to report EPS of -$0.55, down 150% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.09 billion, indicating a 27.51% increase compared to the same quarter of the previous year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$1.42 per share and a revenue of $12.06 billion, representing changes of -1520% and +31.44%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Oscar Health, Inc. presently features a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 61, positioning it in the top 25% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Note
Oscar Health, Inc. (OSCR - Free Report) ended the recent trading session at $20.37, demonstrating a -6.43% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.53% for the day. Elsewhere, the Dow lost 0.71%, while the tech-heavy Nasdaq lost 0.93%.
Shares of the company have appreciated by 22.58% over the course of the past month, outperforming the Finance sector's loss of 2.07%, and the S&P 500's gain of 1.13%.
The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on November 6, 2025. The company is expected to report EPS of -$0.55, down 150% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.09 billion, indicating a 27.51% increase compared to the same quarter of the previous year.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$1.42 per share and a revenue of $12.06 billion, representing changes of -1520% and +31.44%, respectively, from the prior year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Oscar Health, Inc. presently features a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 61, positioning it in the top 25% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.